Esketamine for Treatment-Resistant Depression—Reply
In Reply We acknowledge the questions raised by Klasson and Cristea et al regarding our article1 in JAMA Psychiatry about expectation bias, functional unblinding, design features, and durability of effect, and herein we provide clarification.
Authors
- Richard C. Shelton (ORCID: https://orcid.org/0000-0002-3806-4208)
- Adam Janik
- Dong‐Jing Fu (ORCID: https://orcid.org/0000-0001-6829-0743)
Institutions
- Johnson & Johnson (United States) (US)
- University of Alabama at Birmingham (US)
- University of Alabama in Huntsville (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1001/jamapsychiatry.2025.3248
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00